Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Journal of Personalized Medicine
|
January 19, 2019
The Emerging Role of Checkpoint Inhibition in Microsatellite Stable Colorectal Cancer
David J Hermel, Darren Sigal
Blood Advances
|
June 17, 2026
Low-Dose Vemurafenib Plus Rituximab in Front-Line and Relapsed or Refractory Hairy Cell Leukemia: The Scripps Regimen
David J Hermel, Alan Saven
The New England Journal of Medicine
|
December 18, 2024
Hairy-Cell Leukemia
David J Hermel, Alan Saven
Cancer Metastasis Reviews
|
February 10, 2017
Combining forces: the promise and peril of synergistic immune checkpoint blockade and targeted therapy in metastatic melanoma
David J Hermel, Patrick A Ott
Cancer Metastasis Reviews
|
March 23, 2017
Erratum to: Combining forces: the promise and peril of synergistic immune checkpoint blockade and targeted therapy in metastatic melanoma
David J Hermel, Patrick A Ott
Leukemia & Lymphoma
|
September 1, 2025
Threading through the data for chemotherapy-free alternatives in the treatment of hairy cell leukemia
Danielle Brazel, David J Hermel, Alan Saven
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
September 10, 2025
Evaluation of ambulatory use of daratumumab hyaluronidase injection
Noah Vannarat, David J Hermel, Anne M Spengler
Future Oncology (London, England)
|
November 4, 2021
The role of Globo H and SSEA-4 in the development and progression of cancer, and their potential as therapeutic targets
Darren S Sigal, David J Hermel, Pei Hsu, et al.
Familial Cancer
|
April 30, 2017
Placing negative multi-gene panel results into clinical context
David J Hermel, Wendy C McKinnon, Marie E Wood, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
December 7, 2017
Cardiac birth defects in a twin infant born to a woman with chronic myeloid leukemia on dasatinib
David J Hermel, Victor Chiu, Melody H Hermel, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Journal of Personalized Medicine
|
January 19, 2019
The Emerging Role of Checkpoint Inhibition in Microsatellite Stable Colorectal Cancer
David J Hermel, Darren Sigal
Blood Advances
|
June 17, 2026
Low-Dose Vemurafenib Plus Rituximab in Front-Line and Relapsed or Refractory Hairy Cell Leukemia: The Scripps Regimen
David J Hermel, Alan Saven
The New England Journal of Medicine
|
December 18, 2024
Hairy-Cell Leukemia
David J Hermel, Alan Saven
Cancer Metastasis Reviews
|
February 10, 2017
Combining forces: the promise and peril of synergistic immune checkpoint blockade and targeted therapy in metastatic melanoma
David J Hermel, Patrick A Ott
Cancer Metastasis Reviews
|
March 23, 2017
Erratum to: Combining forces: the promise and peril of synergistic immune checkpoint blockade and targeted therapy in metastatic melanoma
David J Hermel, Patrick A Ott
Leukemia & Lymphoma
|
September 1, 2025
Threading through the data for chemotherapy-free alternatives in the treatment of hairy cell leukemia
Danielle Brazel, David J Hermel, Alan Saven
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
September 10, 2025
Evaluation of ambulatory use of daratumumab hyaluronidase injection
Noah Vannarat, David J Hermel, Anne M Spengler
Future Oncology (London, England)
|
November 4, 2021
The role of Globo H and SSEA-4 in the development and progression of cancer, and their potential as therapeutic targets
Darren S Sigal, David J Hermel, Pei Hsu, et al.
Familial Cancer
|
April 30, 2017
Placing negative multi-gene panel results into clinical context
David J Hermel, Wendy C McKinnon, Marie E Wood, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
December 7, 2017
Cardiac birth defects in a twin infant born to a woman with chronic myeloid leukemia on dasatinib
David J Hermel, Victor Chiu, Melody H Hermel, et al.
Page
of 3